DK130382A - Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf - Google Patents
Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf Download PDFInfo
- Publication number
- DK130382A DK130382A DK130382A DK130382A DK130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- procedure
- production
- quinoline derivatives
- quinoline
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH198681 | 1981-03-24 | ||
| CH198681 | 1981-03-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK130382A true DK130382A (da) | 1982-09-25 |
| DK159427B DK159427B (da) | 1990-10-15 |
| DK159427C DK159427C (da) | 1991-03-18 |
Family
ID=4223231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK130382A DK159427C (da) | 1981-03-24 | 1982-03-23 | Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4476132A (da) |
| EP (1) | EP0062001B1 (da) |
| JP (1) | JPH066576B2 (da) |
| AR (4) | AR242189A1 (da) |
| AT (1) | ATE27451T1 (da) |
| AU (1) | AU560003B2 (da) |
| CY (1) | CY1412A (da) |
| DE (1) | DE3276432D1 (da) |
| DK (1) | DK159427C (da) |
| ES (7) | ES8400092A1 (da) |
| FI (1) | FI77853C (da) |
| GB (1) | GB2095668B (da) |
| GR (1) | GR78345B (da) |
| HK (1) | HK3988A (da) |
| HU (1) | HU192103B (da) |
| IE (1) | IE53158B1 (da) |
| IL (1) | IL65327A0 (da) |
| MY (1) | MY8700806A (da) |
| NO (1) | NO160074C (da) |
| NZ (1) | NZ200106A (da) |
| PT (1) | PT74634B (da) |
| ZA (1) | ZA821957B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58219166A (ja) * | 1982-06-14 | 1983-12-20 | Nippon Shinyaku Co Ltd | ４−キノロン誘導体 |
| JPS58225065A (ja) * | 1982-06-21 | 1983-12-27 | Nippon Shinyaku Co Ltd | ２−キノロン誘導体 |
| US4675432A (en) * | 1986-08-29 | 1987-06-23 | American Cyanamid Company | Method for the preparation of anilinofumarate |
| US6034100A (en) * | 1993-03-10 | 2000-03-07 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting cytokine secretion |
| EE05195B1 (et) * | 2000-10-02 | 2009-08-17 | Janssen Pharmaceutica N.V. | Kinoliini ja kinolinooni derivaadid glutamaatretseptori antagonistidena, nende saamine ja kasutamine ravimite valmistamiseks ning neid sisaldav farmatseutiline kompositsioon |
| AU2003226737B2 (en) * | 2002-03-29 | 2008-09-04 | Janssen Pharmaceutica N.V. | Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| MY189505A (en) | 2012-10-16 | 2022-02-16 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of roryt |
| PE20151203A1 (es) | 2012-10-16 | 2015-08-31 | Janssen Pharmaceutica Nv | MODULADORES DE QUINOLINILO UNIDOS A FENILO DE ROR-GAMMA-t |
| HK1213250A1 (zh) | 2012-10-16 | 2016-06-30 | Janssen Pharmaceutica, N.V. | RORγT的雜芳基連接的喹啉基調節劑 |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| AU2014334619A1 (en) | 2013-10-15 | 2016-04-21 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORyt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| CA2927182A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Quinolinyl modulators of ror.gamma.t |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB830832A (en) * | 1957-02-15 | 1960-03-23 | Ici Ltd | New quinolones and therapeutic compositions containing them |
| GB1013224A (en) * | 1962-06-21 | 1965-12-15 | Ici Ltd | Heterocyclic aminoethanols |
| CH519304A (de) * | 1966-09-29 | 1972-02-29 | Ciba Geigy Ag | Verwendung von heterocyclischen Carbonsäureverbindungen zur Aufzucht von Geflügel |
| US3496184A (en) * | 1969-03-18 | 1970-02-17 | Ciba Geigy Corp | Cyclopropylmethoxy-3-quinoline carboxylic acids and esters |
| DE2103805C3 (de) * | 1970-01-28 | 1980-03-20 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | Verfahren zur Herstellung von N-substituierten 6,7-Methylendioxy-4chinolonen |
| GB1334705A (en) * | 1970-06-19 | 1973-10-24 | Ici Ltd | Pharmaceutical compositions containing kynurenic acid derivatives |
| CA942748A (en) * | 1970-09-18 | 1974-02-26 | Venkatachala L. Narayanan | 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds |
| US4190659A (en) * | 1973-08-27 | 1980-02-26 | Sandoz, Inc. | Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters |
| US4086349A (en) * | 1975-07-30 | 1978-04-25 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma |
| JPS609511B2 (ja) * | 1976-07-16 | 1985-03-11 | 大塚製薬株式会社 | ５−カルボスチリルメタノ−ル誘導体 |
| JPS609713B2 (ja) * | 1976-10-08 | 1985-03-12 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| US4186201A (en) * | 1977-02-07 | 1980-01-29 | Riker Laboratories, Inc. | Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds |
| US4187309A (en) * | 1977-06-20 | 1980-02-05 | Sandoz, Inc. | 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof |
| US4119720A (en) * | 1977-07-06 | 1978-10-10 | Sandoz, Inc. | Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof |
| DE2806879A1 (de) * | 1978-02-17 | 1979-08-23 | Sandoz Ag | 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate |
-
1982
- 1982-03-18 AT AT82810126T patent/ATE27451T1/de not_active IP Right Cessation
- 1982-03-18 DE DE8282810126T patent/DE3276432D1/de not_active Expired
- 1982-03-18 EP EP82810126A patent/EP0062001B1/de not_active Expired
- 1982-03-19 US US06/360,016 patent/US4476132A/en not_active Expired - Lifetime
- 1982-03-22 GR GR67672A patent/GR78345B/el unknown
- 1982-03-22 FI FI820983A patent/FI77853C/fi not_active IP Right Cessation
- 1982-03-22 PT PT74634A patent/PT74634B/pt not_active IP Right Cessation
- 1982-03-23 GB GB8208394A patent/GB2095668B/en not_active Expired
- 1982-03-23 IL IL65327A patent/IL65327A0/xx not_active IP Right Cessation
- 1982-03-23 NZ NZ200106A patent/NZ200106A/en unknown
- 1982-03-23 ES ES510685A patent/ES8400092A1/es not_active Expired
- 1982-03-23 ZA ZA821957A patent/ZA821957B/xx unknown
- 1982-03-23 DK DK130382A patent/DK159427C/da not_active IP Right Cessation
- 1982-03-23 HU HU82881A patent/HU192103B/hu not_active IP Right Cessation
- 1982-03-23 IE IE670/82A patent/IE53158B1/en not_active IP Right Cessation
- 1982-03-23 CY CY141282A patent/CY1412A/en unknown
- 1982-03-23 NO NO820959A patent/NO160074C/no unknown
- 1982-03-23 AU AU81819/82A patent/AU560003B2/en not_active Ceased
- 1982-03-24 AR AR82288857A patent/AR242189A1/es active
- 1982-03-24 JP JP57045754A patent/JPH066576B2/ja not_active Expired - Lifetime
-
1983
- 1983-06-16 ES ES523337A patent/ES8503661A1/es not_active Expired
- 1983-06-16 ES ES523341A patent/ES8503334A1/es not_active Expired
- 1983-06-16 ES ES523338A patent/ES8503662A1/es not_active Expired
- 1983-06-16 ES ES523340A patent/ES8503664A1/es not_active Expired
- 1983-06-16 ES ES523339A patent/ES523339A0/es active Granted
- 1983-06-16 ES ES523342A patent/ES8503665A1/es not_active Expired
- 1983-11-30 AR AR294972A patent/AR240044A1/es active
- 1983-11-30 AR AR83294975A patent/AR242376A1/es active
- 1983-11-30 AR AR29497383A patent/AR240739A1/es active
-
1987
- 1987-12-30 MY MY806/87A patent/MY8700806A/xx unknown
-
1988
- 1988-01-14 HK HK39/88A patent/HK3988A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK112582A (da) | Fremgangsmaade til fremstilling af triazolonderivater | |
| DK66582A (da) | Fremgangsmaade til fremstilling af carbostyrilderivater | |
| DK28282A (da) | Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf | |
| DK162991C (da) | Analogifremgangsmaade til fremstilling af thiazolidinylalkylenpiperazinderivater | |
| DK130382A (da) | Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf | |
| DK160561C (da) | Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf | |
| DK503080A (da) | Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf | |
| DK491582A (da) | Fremgangsmaade til fremstilling af morphinanderivater | |
| DK493083A (da) | Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf | |
| DK276582A (da) | Fremgangsmaade til fremstilling af cephemderivater | |
| DK163580C (da) | Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater | |
| DK63683A (da) | Fremgangsmaade til fremstilling af cephemderivater | |
| DK335882A (da) | Fremgangsmaade til fremstilling af cephemderivater | |
| DK324979A (da) | Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf | |
| DK160555C (da) | Fremgangsmaade til fremstilling af eburnamoninderivater | |
| DK505482A (da) | Fremgangsmaade til fremstilling af pyridinderivater | |
| DK116982A (da) | Fremgangsmaade til fremstilling af alkylendioxybenzenderivater | |
| DK427083A (da) | Fremgangsmaade til fremstilling af cephemderivater | |
| DK438482A (da) | Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf | |
| DK158227C (da) | Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf | |
| DK156219C (da) | Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater | |
| DK224381A (da) | Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf | |
| DK553982A (da) | Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf | |
| DK149823C (da) | Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf | |
| DK476082A (da) | Fremgangsmaade til fremstilling af phenolderivater eller salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment | ||
| PBP | Patent lapsed |